Body

Chinese scientists decode watermelon genome, possible future benefits for crop improvement

November 25, 2012, Shenzhen, China – An international team led by Beijing Academy of Agriculture and Forestry Sciences, BGI, and other institutes has completed the genomic sequence of watermelon (Citrullus lanatus) and the resequencing of 20 watermelon accessions. The genomic data presented in this study will shape future efforts on watermelon genetics and evolutionary research, and also provide an invaluable resource for other plants research and crop genetic improvement. The results were published online in Nature Genetics.

From degeneration to regeneration: Advances in skeletal muscle engineering

A study published today in BioMed Central's open access journal Skeletal Muscle reports of a new therapeutic technique to repair and rebuild muscle for sufferers of degenerative muscle disorders. The therapy brings together two existing techniques for muscle repair – cell transplantation and tissue engineering – specifically, mesoangioblast stem cells delivered via a hydrogel cell-carrier matrix.

Old habits die hard: Helping cancer patients stop smoking

ANN ARBOR—It's a sad but familiar scene near the grounds of many medical campuses: hospital-gowned patients, some toting rolling IV poles, huddled in clumps under bus shelters or warming areas, smoking cigarettes.

Impaired blood vessel function found in cystic fibrosis patients

AUGUSTA, Ga. – The first evidence of blood vessel dysfunction has been found in a small cohort of generally healthy young people with cystic fibrosis, researchers report.

'Repurposed' anti-parasite drug shows promise as new TB treatment: UBC research

A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.

'Repurposed' anti-parasite drug shows promise as new TB treatment: UBC research

A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.

Better blood transfusions for preterm babies

Results of new research from the University of Adelaide are a promising step forward in helping to improve the quality of life-saving blood transfusions for preterm babies, by reducing the likelihood of adverse inflammatory responses to the blood.

Blood transfusions are among the most common medical procedures experienced by preterm babies, who are often anemic and suffer blood loss.

Spanish scientists design a revolutionary data storage device

University of Granada researchers have developed a revolutionary data storage device in collaboration with the CEA-LETI lab at Grenoble (France), an institution of the Campus of International Excellence CEI BioTic. The researchers have designed one of the most advanced data storage devices in the world. The invention is protected with ten international patents including Japan, USA, Corea and the European Union. Important companies such as Samsung and Hynix (Corea) and Micron (USA) have shown interest in this innovative data storage device.

New risk factor identified for high blood pressure during pregnancy

Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine. The cause of preeclampsia is still unclear. Dr. Florian Herse (Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and the Charité), Dr.

A novel therapeutic advancement in the search for heart muscle progenitor cells

CPCs, which are typically only found in fetal development, can become all of the different cell types of the heart and can integrate into heart muscle tissue after injection.

Relaxation good therapy for hot flushes in post-menopausal women

Women who have undergone group therapy and learned to relax have reduced their menopausal troubles by half, according to results of a study at Linköping University and Linköping University Hospital in Sweden.Seven out of every ten women undergoing menopause have at some point experienced problems with hot flushes and sweating. For one in ten women, the problems lasted five years or longer, primarily causing discomfort in social situations and insomnia.The background to this is not known.

Newly discovered effects of vitamin D on cancer

A team of researchers at McGill University have discovered a molecular basis for the potential cancer preventive effects of vitamin D. The team, led by McGill professors John White and David Goltzman, of the Faculty of Medicine's Department of Physiology, discovered that the active form of vitamin D acts by several mechanisms to inhibit both the production and function of the protein cMYC. cMYC drives cell division and is active at elevated levels in more than half of all cancers.

Too much or too little activity bad for knees

CHICAGO – Both very high and very low levels of physical activity can accelerate the degeneration of knee cartilage in middle-aged adults, according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA).

Nearly one in every two people in the U.S. may develop knee osteoarthritis by age 85, according to the Centers for Disease Control and Prevention. By 2030, an estimated 67 million Americans over the age of 18 are projected to have physician-diagnosed arthritis.

Smells like Christmas spirit

PULLMAN, Wash.—Scientists and business people have known for decades that certain scents—pine boughs at Christmas, baked cookies in a house for sale—can get customers in the buying spirit. Eric Spangenberg, a pioneer in the field and dean of the Washington State University College of Business, has been homing in on just what makes the most commercially inspiring odor.

Spangenberg and colleagues at WSU and in Switzerland recently found that a simple scent works best.

Patient's own immune cells may blunt viral therapy for brain cancer

  • People with a type of brain tumor called glioblastoma live 12 months on average, so new forms of treatment for this malignancy are badly needed.
  • Viruses designed to kill cancer cells offer a safe way to treat these tumors, but the therapy doesn't work as well as expected.
  • This study found that a patient's immune system tries to eliminate the anticancer virus and blocking this immune activity gave the virus more time to kill cancer cells.